Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1...
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1...
By Leroy Leo and Christy Santhosh (Reuters) -AbbVie expects a drop in sales volumes of...
(Reuters) – The U.S. Food and Drug Administration on Friday gave accelerated approval for the...
(Reuters) -Shares of Moderna fell 4% on Wednesday after a U.S. judge issued an order...
By Puyaan Singh (Reuters) -Abbott Laboratories said on Tuesday the U.S. FDA has approved its...
By Dietrich Knauth NEW YORK (Reuters) – Rite Aid, one of the largest U.S. pharmacy...
By Patrick Wingrove and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration approved Novo...
By Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) – Novo Nordisk’s widely used diabetes drug...
FRANKFURT (Reuters) -German drugmaker Bayer said on Monday that it was amending its dividend policy...
By Manas Mishra and Sriparna Roy (Reuters) -Biogen on Tuesday forecast flat 2024 product revenue...